Contrary to other tumors, malignant brain tumors such as Grade III anaplastic astrocytoma and Grade IV glioblastoma (GBM) express RXFP1 but fail to express RLN2 (Glogowska et al., 2013). This evidence concerns the gene RXFP1 and glioblastoma.